学术探索
学术期刊
新闻热点
数据分析
智能评审

SYNERGISTIC COMBINATION OF AZITHROMYCIN AND SULFADIAZINE FOR TREATMENT OF TOXOPLASMOSIS IN MICE

被引：10
作者：
ARAUJO, FG
LIN, T
REMINGTON, JS
机构：
[1] PALO ALTO MED FDN,RES INST,860 BRYANT ST,PALO ALTO,CA 94301
[2] STANFORD UNIV,MED CTR,SCH MED,DEPT MED,DIV INFECT DIS,STANFORD,CA 94305
来源：
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 1992年 / 11卷 / 01期
关键词：
D O I：
10.1007/BF01971278
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Experiments were performed in vivo in a mouse model of acute toxoplasmosis to evaluate the effectiveness of the combination azithromycin/sulfadiazine. Azithromycin alone or sulfadiazine alone, at doses that did not provide any protection against death due to toxoplasmosis, were remarkably and significantly synergistic against murine toxoplasmosis when administered in combination.
引用
收藏
页码：71 / 73
页数：3
相关论文
共 16 条
12